341 related articles for article (PubMed ID: 4156665)
1. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
2. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
Donlon PT; Rada RT
Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
[TBL] [Abstract][Full Text] [Related]
3. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
Amin MM; Brahm E; Ban TA; Lehmann HE
Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
[No Abstract] [Full Text] [Related]
4. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
[No Abstract] [Full Text] [Related]
5. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
Matkowski K; Sep-Kowalikowa B
Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
[No Abstract] [Full Text] [Related]
6. A controlled study of mesoridazine: an effective treatment for schizophrenia.
McIndoo MV
South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
[No Abstract] [Full Text] [Related]
7. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
Ban TA; Ananth JV; Lehmann HE
Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
[No Abstract] [Full Text] [Related]
8. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
Gallant DM; Bishop MP
Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
[No Abstract] [Full Text] [Related]
9. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
Kiev A; Güclü B; Kulkarni AS
Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
[No Abstract] [Full Text] [Related]
10. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
Hollister LE
Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
[No Abstract] [Full Text] [Related]
11. The effect of rubidium in schizophrenia.
Chouinard G; Annable L
Commun Psychopharmacol; 1977; 1(4):373-83. PubMed ID: 28202
[No Abstract] [Full Text] [Related]
12. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
Kulkarni AS
Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
[No Abstract] [Full Text] [Related]
13. Piperacetazine in the treatment of mixed neurotics.
Lapierre YD; Lee M
Curr Ther Res Clin Exp; 1976 Jan; 19(1):105-9. PubMed ID: 1209
[No Abstract] [Full Text] [Related]
14. Piperacetazine study in state hospital patients.
del Portillo L
J Med Assoc Ga; 1974 Dec; 63(12):465-7. PubMed ID: 4154960
[No Abstract] [Full Text] [Related]
15. Specific indications for different classes of phenothiazines.
Hollister LE; Overall JE; Kimbell I; Pokorny A
Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
[No Abstract] [Full Text] [Related]
16. Potential value of penfluridol and pipothiazine palmitate.
Gallant DM
Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769
[No Abstract] [Full Text] [Related]
17. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
Salvesen C; Vaksdal K
PDM; 1974; 5-6(9-12;1-8):10-4. PubMed ID: 4156935
[No Abstract] [Full Text] [Related]
18. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
Zwanikken GJ
Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
[No Abstract] [Full Text] [Related]
19. A clinical study with propericiazine in chronic psychotic patients.
Deutsch M; Ananth JV; Ban TA
Curr Ther Res Clin Exp; 1971 Jun; 13(6):353-8. PubMed ID: 4397391
[No Abstract] [Full Text] [Related]
20. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
Brotman RK; Muzekari LH; Shanken PM
Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
